WPI 3720 (Tranexamic Acid 650 mg)
Pill with imprint WPI 3720 is White, Elliptical / Oval and has been identified as Tranexamic Acid 650 mg. It is supplied by Watson Laboratories, Inc..
Tranexamic acid is used in the treatment of menorrhagia; menstrual disorders; bleeding disorder; hemophilia a; factor ix deficiency and belongs to the drug class miscellaneous coagulation modifiers. There is no proven risk in humans during pregnancy. Tranexamic acid 650 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3720
Tranexamic Acid
- Imprint
- WPI 3720
- Strength
- 650 mg
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3720 | Watson Pharmaceuticals, Inc. |
| 68084-0929 | Amerisource Health Services |
More about tranexamic acid
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 235 Reviews
- Drug class: miscellaneous coagulation modifiers
- FDA Alerts (1)
Consumer resources
- Patient Information
- Tranexamic acid (Advanced Reading)
- Tranexamic acid Intravenous (Advanced Reading)
- Tranexamic Acid Tablets
- Tranexamic Acid Injection
- Other brands
- Lysteda, Cyklokapron
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.